The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Association Between Cell-Free Hemoglobin, Acetaminophen, and Mortality in Patients With Sepsis: An Observational Study*
Open accessAbstract
OBJECTIVE: To determine the association of circulating cell-free hemoglobin with poor clinical outcomes in patients with sepsis and to characterize the potential protective effects of acetaminophen, an inhibitor of hemoprotein-mediated oxidation. DESIGN: Retrospective observational study. PATIENTS: A total of 391 critically ill patients with sepsis in multiple ICUs in an academic tertiary care hospital. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Nonsurvivors had significantly higher plasma cell-free hemoglobin concentrations (median 20mg/dL, interquartile range 10-40) measured on enrollment compared to survivors (10mg/dL, interquartile range 10-30, p = 0.002). After controlling for potential confounders, patients with higher cell-free hemoglobin concentrations were significantly more likely to die in the hospital (odds ratio 1.078, 95% confidence interval 1.012-1.149, p = 0.02). In addition, receiving acetaminophen in the setting of increased cell-free hemoglobin was independently associated with a protective effect against death (odds ratio 0.48, 95% confidence interval 0.25-0.91, p = 0.026) and lower plasma concentrations of the lipid peroxidation product F2-isoprostanes (18.5 pg/mL, interquartile range 9-22.2) compared to no acetaminophen (42 pg/mL, interquartile range 29.7-86, p = 0.009). CONCLUSIONS: In critically ill patients with sepsis, elevated concentrations of circulating cell-free hemoglobin are independently associated with an increased risk of death. Acetaminophen may exert a protective effect by reducing cell-free hemoglobin-induced oxidative injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The clinical relevance of this pathologic process is strongly supported by the finding that accumulation of extracellular hemoglobin is associated with higher risk of death from severe sepsis [193,194].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [193]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 3×
“various vascular beds (1, 2, 6, 8, 9), neutrophil activation (10),”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Natanson, C., Kern, S. J., Lurie, P., Banks, S. M., & Wolfe, S. M. (2008) · JAMA · doi:10.1001/jama.299.19.jrv80007 · Cited by 622
Donadee, C., Raat, N. J. H., Kanias, T., Tejero, J., Lee, J. S., Kelley, E. E., Zhao, X., Liu, C., Reynolds, H., Azarov, I., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008698 · Cited by 572 · cited 2×
“various vascular beds (1, 2, 6, 8, 9), neutrophil activation (10),”
BackgroundA Central Role for Free Heme in the Pathogenesis of Severe Sepsis
Larsen, R., Gozzelino, R., Jeney, V., Tokaji, L., Bozza, F. A., Japiassú, A. M., Bonaparte, D., Cavalcante, M. M., Chora, Â., Ferreira, A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001118 · Cited by 483 · cited 2×
“org 785 of haptoglobin, hemopexin, or heme oxygenase-1 (18).”
BackgroundMinneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 331 · cited 2×
“various vascular beds (1, 2, 6, 8, 9), neutrophil activation (10),”
BackgroundNeutrophil activation by heme: implications for inflammatory processes
Graça-Souza, A. V., Arruda, M. A. B., de Freitas, M. S., Barja-Fidalgo, C., & Oliveira, P. L. (2002) · Blood · doi:10.1182/blood.v99.11.4160 · Cited by 295
Research works printed but not linked: 1
- Reeder, 2004, Antioxid Redox Signal, 6, 954
Cited by
Items 101–169 of 169
Zemtsovski, J. D., Tumpara, S., Schmidt, S., Vijayan, V., Klos, A., Laudeley, R., Held, J., Immenschuh, S., Wurm, F. M., Welte, T., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368040 · Cited by 7
“Severe sepsis is associated with reduced plasma concentrations of hemopexin, the top heme-binding protein (51).”
BackgroundShao, W.-M., Ye, L., Zhang, L., Wang, Y., Liu, H., He, D., Zhu, J.-L., Lyu, J., & Yin, H. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09476-w · Cited by 7
“This free HGB precipitates inflammatory reactions, subsequently impairing bodily tissues and organs [33].”
BackgroundLi, L., Zhang, L., Ye, Y., Su, Q., Leong, K. F., Yin, H., Gu, W., & Ma, M. (2024) · BMC Anesthesiology · doi:10.1186/s12871-024-02756-7 · Cited by 6
“Another retrospective observational study found that acetaminophen had a protective association with in-hospital mortality by reducing CFH-induced oxidative injury [6].”
Verma, T., Majumdar, S., Yadav, S., Ahmed, S. M., Umapathy, S., & Nandi, D. (2021) · The Analyst · doi:10.1039/d1an00066g · Cited by 7
Domizi, R., Damiani, E., Carsetti, A., Graciotti, L., Procopio, A. D., Scorcella, C., Casarotta, E., Giaccaglia, P., Donati, A., & Adrario, E. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01251-z · Cited by 7
“The group of Janz et al. demonstrated that receiving acetaminophen in a context of sepsis, with increased cell-free Hb, was associated with lower plasma concentration of oxidative injury markers and lower risk of death in hospital, independent of the other risk factors for poor outcomes [14,15, 16].”
BackgroundInfluentialUnusual Case of Thrombosis in LVAD Patient with COVID-19 — Diagnostic Challenges
Frick, W. H., Mallory, R., Guglin, M. E., Anderson, E., Lushin, E. N., Vivo, R. P., Saleem, K., & Rao, R. A. (2020) · The VAD Journal · doi:10.11589/vad/e2020622 · Cited by 6
“Cell-free hemoglobin elevations have also been shown to occur and predict poor outcomes in sepsis in non-LVAD patients.(7)”
BackgroundMuljono, M. P., Halim, G., Heriyanto, R. S., Meliani, F., Budiputri, C. L., Vanessa, M. G., Andraina, Juliansen, A., & Octavius, G. S. (2022) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-022-00123-0 · Cited by 6
“and blood dilution caused by liquid expansion lowers the hematocrit level [31, 32].”
BackgroundLi, X. L., Dong, P., Tian, M., Ni, J., & Smith, F. G. (2015) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-015-0330-x · Cited by 6
Arikawa, A. Y., Samavat, H., Gross, M. D., & Kurzer, M. S. (2017) · Journal of Nutrition · doi:10.3945/jn.117.254631 · Cited by 6
Chowdhury, A., Powell, R. E., Kennedy, J. N., Urbanek, K., Angus, D., Chang, C.-C. H., Tang, L., Weis, S., Bauer, M., Shankar‐Hari, M., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08404-7 · Cited by 6
Kasper, R., Rodríguez, A., Ständker, L., Wiese, S., & Schneider, E. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1359097 · Cited by 6
Counterpoint: Are the Best Patient Outcomes Achieved When ICU Bundles Are Rigorously Adhered To? No
Marik, P. E., Raghunathan, K., & Bloomstone, J. A. (2013) · CHEST Journal · doi:10.1378/chest.13-0848 · Cited by 5
Purified and Recombinant Hemopexin: Protease Activity and Effect on Neutrophil Chemotaxis
Lin, T., Liu, J., Huang, F., van Engelen, T. S. R., Thundivalappil, S. R., Riley, F. E., Super, M., Watters, A. L., Smith, A., Brinkman, N. J., et al. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00006 · Cited by 5
Marik, P. E. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828cec2d · Cited by 5
Wang, T., Yin, H., Shen, G., Cao, Y., Qin, X., Xu, Q., Qi, Y., Jiang, X., & Lu, W. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03379-x · Cited by 4
“In addition, the study conducted by Janz et al. suggested that acetaminophen may exert a protective effect in critically ill patients with sepsis, potentially through its ability to mitigate oxidative damage caused by acellular hemoglobin [12].”
A novel process for transcellular hemoglobin transport from macrophages to cancer cells
Braniewska, A., Skorzynski, M., Sas, Z., Długołęcka, M., Marszałek, I., Kurpiel, D., Bühler, M., Strzemecki, D., Karpińska, A., Białasek, M., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01929-8 · Cited by 6
“Free Hb concentrations of 10–20 mg ml − 1 have been reported in critically ill patients [44].”
Bünger, V., Menk, M., Hunsicker, O., Krannich, A., Balzer, F., Spies, C., Kuebler, W. M., Weber‐Carstens, S., & Graw, J. A. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-02988-1 · Cited by 4
“Hemolysis is a common complication in critically ill patients with sepsis, the acute respiratory distress syndrome (ARDS), or therapy with extracorporeal membrane oxygenation (ECMO) [1–5].”
Afzal, A., Beavers, W. N., Skaar, E. P., Calhoun, M. C., Richardson, K. A., Landstreet, S. R., Cliffel, D. E., Wright, D. W., Bastarache, J. A., & Ware, L. B. (2022) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2022.102699 · Cited by 4
Self-citationUnderstanding the Vital Signs: BP, HR, RR, TEMP, SaO2 … and SV
Marik, P. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-11020-2_14 · Cited by 5
Die Bedeutung der Hämolyse in Anästhesie und Intensivmedizin
Graw, J. A., Baron, D. M., & Francis, R. C. E. (2018) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/s-0043-121622 · Cited by 7
“[65] Janz DR, Bastarache JA, Peterson JF et al.”
BackgroundFanning the Fire: Can Methemoglobin Enhance Neutrophil Activation?
Bastarache, J. A., Wynn, J. L., & Ware, L. B. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.01.019 · Cited by 4
“In recent years, our group and others have described high levels of circulating cell-free hemoglobin (Hb) in the majority of patient with sepsis (Janz et al., 2013; Adamzik et al., 2012) and have shown that higher levels are associatedwith poor clinical outcomes.”
BackgroundSelf-citationEffect of Acetaminophen on the Prevention of Acute Kidney Injury in Patients With Sepsis
Patanwala, A. E., Aljuhani, O. A., Bakhsh, H. T., & Erstad, B. L. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017728298 · Cited by 4
Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury
Kewalramani, N., Machahua, C., Marti, T. M., Zandbergen, C., Chortarea, S., Beretta-Piccoli, J., von Garnier, C., Dorn, P., Fytianos, K., & Funke-Chambour, M. (2025) · Respiratory Research · doi:10.1186/s12931-025-03191-z · Cited by 3
“Higher mortality was also associated with increased circulating cell-free hemoglobin (CFH) in severe sepsis patients [11].”
Meegan, J. E., Riedmann, K. J., Gonski, S. K., Douglas, J. S., Bogart, A. M., Ware, L. B., & Bastarache, J. A. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00026.2025 · Cited by 5
“The concentrations of Hb and LDL were physiological and were chosen based on published studies (8, 15, 22).”
Self-citationYu, H., Yang, T., & Liu, D. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241290210 · Cited by 5
“17,31,32 In addition, acetamino-phen prevents oxidative damage and renal failure due to rhabdomyolysis-induced release of the blood protein myoglobin.”
Acetaminophen and Clinical Outcomes in Sepsis
Obeidalla, S. N., Bernard, G. R., Ware, L. B., & Kerchberger, V. E. (2024) · CHEST Critical Care · doi:10.1016/j.chstcc.2024.100118 · Cited by 7
“6 Although acetaminophen is used commonly in patients who are critically ill for fever reduction and analgesia, data on the therapeutic effects of acetaminophen in sepsis are conflicting.”
InfluentialSelf-citationMeegan, J. E., Kerchberger, V. E., Fortune, N. L., McNeil, J. B., Bastarache, J. A., Austin, E. D., Ware, L. B., Hemnes, A. R., & Brittain, E. L. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12185 · Cited by 4
Self-citationThe precautionary principle and use of Group A plasma in recipients of unknown ABO blood group
Blumberg, N., Heal, J. M., Masel, D., & Refaai, M. A. (2018) · Transfusion · doi:10.1111/trf.14466 · Cited by 3
“It is believed that more moderate, not easily visualized hemolysis contributes to severe morbidity in sickle cell anemia and paroxysmal nocturnal hemoglobinuria, as well as being a prognostic marker for mortality in critically ill patients.(7,8) Such patients, independent of the etiology of increased free hemoglobin,…”
BackgroundBünger, V., Menk, M., Hunsicker, O., Krannich, A., Balzer, F., Spies, C., Kuebler, W. M., Weber‐Carstens, S., & Graw, J. A. (2025) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007495 · Cited by 2
Huang, F., Yi, J., Zhou, T., & Gong, X. (2025) · European journal of medical research · doi:10.1186/s40001-025-02786-y · Cited by 5
“An independent observational study on critically ill septic patients also indicated that acetaminophen potentially improved survival by reducing oxidative damage caused by cell-free hemoglobin [13].”
Early acetaminophen Use and 90-day mortality in ICU patients with ischemic stroke
Piao, Z.-S., Zhang, Y., Li, G., Jia, Y., & Cheng, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1622440 · Cited by 2
THE IMPACT OF SCHISTOCYTE DETECTION ON MORTALITY AND ORGAN FAILURE IN PATIENTS WITH SEPSIS
Tanaka, T., Fujino, K., Tsujita, Y., Matsumoto, Y., Fujino, M., Miyatake, H., Mizumura, N., Kato, T., Shimizu, J., Kishimoto, T., et al. (2024) · Shock · doi:10.1097/shk.0000000000002440 · Cited by 2
Kubanek, A., Sulima, M., Szydłowska, A., Sikorska, K., & Renke, M. (2024) · Pathogens · doi:10.3390/pathogens13100851 · Cited by 2
“In some studies, it was shown that acetaminophen decreased oxidant injury in the kidneys, improved renal function, and reduced renal damage in rhabdomyolysis-induced renal failure [25,26].”
BackgroundCell-Free Hemoglobin: A New Therapeutic Target in Sepsis?
Ware, L. B. (2020) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-37323-8_23 · Cited by 3
Self-citationPaasi, G., Namayanja, C., Ongodia, P., Okalebo, C. B., Okiror, W., Abongo, G., Masifa, G., Amorut, D., Muhindo, R., Olupot‐Olupot, P., et al. (2026) · Trials · doi:10.1186/s13063-026-09432-w · Cited by 1
“Our findings contrast with studies in adult populations with AKI [17, 18, 28, 29] however, given the pilot sample size and resulting imprecision, these differences between our findings and adult studies should be interpreted cautiously, since both a clinically meaningful benefit and no effect…”
The poikilothermic hypothesis of sepsis
Fan, R. R., & Gautron, L. (2026) · Critical Care · doi:10.1186/s13054-026-05879-0 · Cited by 2
“Some studies have found that fever control with acetaminophen or physical cooling may potentially lower early mortality in severely ill patients [63–65].”
Intravascular hemolysis aggravates ventilator-induced lung injury in mice
Buttenberg, M., Bünger, V., Taher, M., Höfer, N., Rinderknecht, H., Relja, B., Klopfleisch, R., Francis, R. C. E., Kuebler, W. M., & Graw, J. A. (2026) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2025 · Cited by 1
Integrated Model Linking Hemolysis, NETosis, Ferroptosis, Lysosomal Dysfunction, and DIC in Sepsis
Iba, T., Maier, C. L., Ferrer, R., Nagaoka, I., Wada, H., & Levy, J. H. (2026) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2920-1243 · Cited by 1
Haemolytic injury and cardiovascular disease
Hieromnimon, M. C., Basit, A., Hieromnimon, H. M., Newby, L. K., Gladwin, M. T., & Applefeld, W. N. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01329-0 · Cited by 1
Pathophysiology of sepsis-associated AKI [SA-AKI]
Doradla, L. P. S., & Prasad, N. (2016) · Clinical Queries Nephrology · doi:10.1016/j.cqn.2016.04.005 · Cited by 1
Wu, Y., Chung, H.-W., Chen, Y.-T., Chen, H.-C., Chen, I.-H., & Su, W. (2024) · Biomedicines · doi:10.3390/biomedicines12122789 · Cited by 1
Gui, L., Cao, H., Zheng, M., Pan, Y., Ning, C., & Cheng, M. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03421-x · Cited by 1
“…as those undergoing hemodialysis [24], malaria [25], and CABG surgeries [26, 27] etc. APAP may provide protection by minimizing CFH-induced oxidative damage by binding to divalent iron (Fe 2+ ) in CFH and converting it to less reactive trivalent iron (Fe 3+ ) at clinically relevant doses [28–31].”
Marik, P. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-11020-2_12 · Cited by 1
Graw, J. A. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-6024 · Cited by 1
“21037/atm-22-6024 with increased mortality in patients with sepsis (3).”
BackgroundHemoglobin—Unchained and Causing Harm in Sepsis?*
Greenberg, J. A., & Poston, J. T. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182770570
“In detail, StO 2 values < 78% were associated with increased mortality at day 28 (5).”
BackgroundTom, J., Jakubec, P. J., & Andreas, H. A. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.05.164
Deficiency in reverse cholesterol transport in mice augments sepsisPreprint
Wang, Q., Guo, L., Hao, D., Ito, M., Yu, K., Wang, R., Mineo, C., Shaul, P. W., & Li, X. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.26.051250
“In clinical study, sepsis caused hemolysis that massive hemoglobin release from red blood cells is a risk factor of septic death(30,32).”
BackgroundJanz, D. R., & Ware, L. B. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182963bce
Self-citationZhang, S., Xu, S., Liao, R., & Qin, K. (2023) · Oncology and Translational Medicine · doi:10.1007/s10330-023-0637-7
Changes in Erythrocytes and Their Degradation Products under the Influence of the SARS-COV-2 Virus
Golubeva, M. G. (2024) · Biology Bulletin Reviews · doi:10.1134/s207908642460019x · Cited by 1
“The key previously known triggers of hemolysis in sepsis are: transfusion reactions (Adamzik et al., 2012), complement activation (Janz et al., 2013) and disseminated intravascular coagulation (Hartmann and De Groot, 2013), capillary arrest of blood flow (Pita Zapata et al., 2010), limiting the…”
Changes in Erythrocytes and their Degradation Products under the Influence of the SARS-CoV-2
Golubeva, M. G. (2024) · Успехи современной биологии · doi:10.31857/s0042132424020055
Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis
Files, D. C., Matthay, M. A., Ware, L. B., Brower, R. G., Aggarwal, N. R., Brown, S. M., Chang, S. Y., Douglas, I. S., Duggal, A., Gibbs, K. W., et al. (2025) · CHEST Critical Care · doi:10.1016/j.chstcc.2025.100168
“17 Baseline cell-free hemoglobin by treatment interactions for continuous efficacy outcomes (primary end point and the organ support components of the primary end point) were assessed by an analysis of variance model.”
Self-citationPaasi, G., Namayanja, C., Ongodia, P., Okalebo, C. B., Okiror, W., Abong, G., Masifa, G., Amorut, D., Muhindo, R., & Olupot‐Olupot, P. (2025) · Research Square · doi:10.21203/rs.3.rs-7081209/v1
Li, J., Li, Y., Zhong, M., Chen, H., Wang, Z., Wu, J., & Shi, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1588978
Reuß, C. J., Bernhard, M., Beynon, C., Fiedler-Kalenka, M. O., Hecker, A., Jungk, C., Michalski, D., Schmitt, F. C. F., Weigand, M. A., Brenner, T., et al. (2025) · Die Anaesthesiologie · doi:10.1007/s00101-025-01589-4
Liu, J., Xie, B., Zhou, Y.-F., Yi, X., & Cui, X.-J. (2025) · Medicine · doi:10.1097/md.0000000000044744
“[40,41] In clinical practice, the effects and risks of side effects of APAP treatment should be fully evaluated for hypertensive patients, especially when such drugs have to be used for treatment, as other antipyretic analgesics (such as NASIDs) also have cardiovascular related risks, and even…”
Domizi, R., Damiani, E., Carsetti, A., Graciotti, L., Procopio, A. D., Scorcella, C., Casarotta, E., Giaccaglia, P., Donati, A., & Adrario, E. (2024) · Figshare · doi:10.6084/m9.figshare.26679530
Domizi, R., Damiani, E., Carsetti, A., Graciotti, L., Procopio, A. D., Scorcella, C., Casarotta, E., Giaccaglia, P., Donati, A., & Adrario, E. (2024) · Figshare · doi:10.6084/m9.figshare.26679521
Domizi, R., Damiani, E., Carsetti, A., Graciotti, L., Procopio, A. D., Scorcella, C., Casarotta, E., Giaccaglia, P., Donati, A., & Adrario, E. (2024) · Figshare · doi:10.6084/m9.figshare.26679524
Shao, W., Ye, L.-W., Zhang, L.-M., Wang, Y.-L., Liu, H., He, D., Zhu, J.-L., Lyu, J., & Yin, H. (2024) · Figshare · doi:10.6084/m9.figshare.26019734
Graw, J. A., Hildebrandt, P., Krannich, A., Balzer, F., Spies, C., Francis, R. C., Kuebler, W. M., Weber-Carstens, S., Menk, M., & Hunsicker, O. (2022) · Figshare · doi:10.6084/m9.figshare.19219482
Shao, W., Ye, L.-W., Zhang, L.-M., Wang, Y.-L., Liu, H., He, D., Zhu, J.-L., Lyu, J., & Yin, H. (2024) · Figshare · doi:10.6084/m9.figshare.26019554
Shao, W., Ye, L.-W., Zhang, L.-M., Wang, Y.-L., Liu, H., He, D., Zhu, J.-L., Lyu, J., & Yin, H. (2024) · Figshare · doi:10.6084/m9.figshare.26732587
Domizi, R., Damiani, E., Carsetti, A., Graciotti, L., Procopio, A. D., Scorcella, C., Casarotta, E., Giaccaglia, P., Donati, A., & Adrario, E. (2024) · Figshare · doi:10.6084/m9.figshare.26679527
Piao, Z.-S., Wang, Y.-F., & Cheng, K. (2026) · BMC Neurology · doi:10.1186/s12883-025-04553-2
“Similarly, while some analyses in febrile populations have not demonstrated significant effects on all-cause mortality after adjusting for confounders, other investigations have reported survival benefits in patients with critical illness and sepsis [17, 19].”
Diet-induced obesity alleviates epithelial damage in hyperoxic acute lung injury (HALI) in mice
Kampelmann, M., Pich, A., Mühlfeld, C., & Schipke, J. (2026) · Respiratory Research · doi:10.1186/s12931-026-03663-w
Gucwa, D., Such, A., & Kołaczkowska, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1917185
“…clinically relevant levels of hemolysis (0.1 – 1 mg/ml with 0.15-0.4 mg/ml representing the range most frequently reported in patients with sepsis) (26 – 29), while the lowest and highest conditions were included to extend the experimental range and provide insight into cellular responses under…”
Influential
Metadata
- Authors
- Janz, D. R., Bastarache, J. A., Peterson, J. F., Sills, G., Wickersham, N., May, A. K., Roberts, L. J., & Ware, L. B.
- Affiliations
- Vanderbilt University (US)
- Venue
- Critical Care Medicine
- Published
- 2013-03
- Volume
- 41
- Issue
- 3
- Pages
- 784-790
- ISSN
- 0090-3493 (ISSN-L)
- PMC
- PMC3578977
- OpenAlex
- W2038586688
- Cited by
- 169
- References
- 28
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 29 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 8 · 2018: 12 · 2017: 9 · 2016: 11 · 2015: 10 · 2014: 15 · 2013: 10
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K24HL103836, HL 090785, HL103836, K08HL090785, U01HL081332, R21HL112656, T32HL087738)
- National Institute of General Medical Sciences (GM 42056, P01GM015431, R01GM042056, R37GM042056)
- National Center for Research Resources (UL1RR024975)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- free hemoglobin, sepsis, paracetamol, mortality, critically ill patients, oxidative stress, lipid peroxidation, F2-isoprostanes, prognostic factors
- MeSH terms
- Acetaminophen, Aged, Cell-Free System, Female, Hemoglobins, Humans, Intensive Care Units, Male, Middle Aged, Retrospective Studies, Confidence Intervals, Logistic Models, Odds Ratio, Hospital Mortality, Oxidative Stress, Analgesics, Non-Narcotic, Sepsis, F2-Isoprostanes, Qualitative Research, Tertiary Care Centers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.